Literature DB >> 27843805

Impaired Repressor Function in SUMOylation-Defective Thyroid Hormone Receptor Isoforms.

Joachim M Weitzel1.   

Abstract

BACKGROUND: Many nuclear receptors are modified by posttranslational modifications.
OBJECTIVES: The transcriptional activity of thyroid hormone receptors (TRs) is modified by the influence of its ligand (thyroid hormones T3 and T4), but is also affected by posttranslational modifications. This study focuses on the SUMOylation of TR isoforms and the consequences on transcriptional activity and promoter occupancy.
METHODS: SUMOylation of TR wild-type as well as isoform-specific point mutations have been studied in vitro. The promoter occupancy of TR (wild-type and double- or triple-mutated versions) and transcriptional cofactors have been investigated in chromatin immunoprecipitation (ChIP) and Re-ChIP analysis.
RESULTS: TR is modified by SUMO proteins at defined residues: the isoform TRα is mainly modified at lysines 281 and 387, whereas lysines 50 and 443 are major SUMOylation sites of isoform TRβ. Lysine residues K281 (TRα) and K50 (TRβ) are isoform-specific SUMOylation sites influencing differing TR domains, whereas K387 (TRα) and K443 (TRβ) are orthologous residues. TRs are targets of all three SUMO variants (SUMO-1, -2, and -3). The transcriptional activity of SUMOylation-defective mutants of TR alters gene transcription from positively and negatively regulated T3 target genes.
CONCLUSIONS: The most pronounced effect is an impaired repressor function of SUMOylation-deficient TR in the absence of T3. The transcriptional properties of SUMOylation-defective TRs can be at least in part ascribed to altered interaction with transcriptional cofactors such as SRC-1 and NCoR. Thus, these data indicate that posttranslational modification of TR by SUMOylation contribute to the fine tuning of its transcriptional response maintaining effects on cellular and physiological homeostasis.

Entities:  

Keywords:  Gene expression; Ligand-dependent transcription factor; Posttranslational modification; SUMO; Transrepression

Year:  2016        PMID: 27843805      PMCID: PMC5091228          DOI: 10.1159/000447232

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  35 in total

Review 1.  SUMO, ubiquitin's mysterious cousin.

Authors:  S Müller; C Hoege; G Pyrowolakis; S Jentsch
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

2.  T3-mediated expression of PGC-1alpha via a far upstream located thyroid hormone response element.

Authors:  Anne Wulf; Angelika Harneit; Meike Kröger; Maxim Kebenko; Marianne G Wetzel; Joachim M Weitzel
Journal:  Mol Cell Endocrinol       Date:  2008-02-03       Impact factor: 4.102

3.  Cell biology: SUMO.

Authors:  Erik Meulmeester; Frauke Melchior
Journal:  Nature       Date:  2008-04-10       Impact factor: 49.962

Review 4.  Thyroid hormones and mitochondria: with a brief look at derivatives and analogues.

Authors:  Federica Cioffi; Rosalba Senese; Antonia Lanni; Fernando Goglia
Journal:  Mol Cell Endocrinol       Date:  2013-06-13       Impact factor: 4.102

Review 5.  Coordination of mitochondrial biogenesis by thyroid hormone.

Authors:  Joachim M Weitzel; K Alexander Iwen
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

6.  Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors.

Authors:  A Dace; L Zhao; K S Park; T Furuno; N Takamura; M Nakanishi; B L West; J A Hanover; S Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone.

Authors:  Pragya Sharma; Shalini Thakran; Xiong Deng; Marshall B Elam; Edwards A Park
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

8.  SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes.

Authors:  Sung Soo Chung; Byung Yong Ahn; Min Kim; Jun Ho Kho; Hye Seung Jung; Kyong Soo Park
Journal:  Biochem J       Date:  2011-01-01       Impact factor: 3.857

Review 9.  Molecular aspects of thyroid hormone actions.

Authors:  Sheue-Yann Cheng; Jack L Leonard; Paul J Davis
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

10.  Identification of the putative MAP kinase docking site in the thyroid hormone receptor-beta1 DNA-binding domain: functional consequences of mutations at the docking site.

Authors:  Hung-Yun Lin; ShenLi Zhang; Brian L West; Heng-Yuan Tang; Teresa Passaretti; Faith B Davis; Paul J Davis
Journal:  Biochemistry       Date:  2003-06-24       Impact factor: 3.162

View more
  2 in total

Review 1.  Thyroid hormone receptor localization in target tissues.

Authors:  Cyril S Anyetei-Anum; Vincent R Roggero; Lizabeth A Allison
Journal:  J Endocrinol       Date:  2018-02-12       Impact factor: 4.286

2.  Acetylation modulates thyroid hormone receptor intracellular localization and intranuclear mobility.

Authors:  Cyril S Anyetei-Anum; Rochelle M Evans; Amanda M Back; Vincent R Roggero; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2019-07-15       Impact factor: 4.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.